Teva Pharmaceutical Industries (TEVA) EPS (Basic) (QoQ) (2009 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.60 Bn | 38.95 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 411.09 Mn | 369.84 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -254.47% |
| Mar 31, 2026 | -22.03% |
| Dec 31, 2025 | 8.99% |
| Sep 30, 2025 | 53.74% |
| Jun 30, 2025 | 26.73% |
| Mar 31, 2025 | 179.51% |
| Dec 31, 2024 | 29.90% |
| Sep 30, 2024 | 55.14% |
| Jun 30, 2024 | -267.30% |
| Mar 31, 2024 | 10.98% |
| Dec 31, 2023 | 514.25% |
| Sep 30, 2023 | 108.37% |
| Jun 30, 2023 | -256.90% |
| Mar 31, 2023 | 81.12% |
| Dec 31, 2022 | -2,186.25% |
| Sep 30, 2022 | 123.00% |
| Jun 30, 2022 | 71.51% |
| Mar 31, 2022 | -541.46% |
| Dec 31, 2021 | -149.39% |
| Sep 30, 2021 | 45.71% |